SkinHealth Systems lowered its full-year revenue outlook to a range of $280 million to $290 million while raising its adjusted EBITDA guidance to $39 million to $46 million and scheduling a September 22 shareholder vote on a reverse stock split to maintain NASDAQ compliance. CEO Pedro Malha described second-quarter results as mixed, with revenue of $72.1 million at the low end of guidance and equipment sales remaining a headwind as providers stay cautious on capital investments, though adjusted EBITDA of $17 million exceeded expectations due to strong gross margins and cost discipline. CFO Michael Monahan said the company received a NASDAQ notice after its stock traded below the $1 minimum bid price for 30 days and will seek stockholder approval for a reverse split at the special meeting. The company also introduced a U.S. device rental program with a third-party financing partner to lower upfront costs for providers and expand access to Hydrafacial. For the third quarter, SkinHealth guided revenue of $65 million to $70 million and adjusted EBITDA of $5 million to $7 million, while projecting second-half adjusted EBITDA will decline from the first half as it increases R&D and commercial investments by $4 million.
Beauty Health CoLowered revenue outlook and weak equipment sales, though EBITDA guidance raised.
